Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
Withdrawn before enrolling · Phase 4
Conditions studied: Demyelinating Disorders, Multiple Sclerosis, Optic Neuritis, Myelitis, Neuritis
In brief
The participant will receive weekly intramuscular treatment with AVONEX® (interferon beta 1-a) and a one-time high dose intravenous methotrexate with Leucovorin rescue, along with the standard solumedrol treatment before beginning AVONEX® treatment.
Key facts
- Study ID
- NCT00037115
- Run by
- MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
- People needed
- 0
- Starts
- 2002-05-01
- Expected to finish
- 2002-12-01
- Last updated by the study team
- 2018-04-12
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MidAmerica Neuroscience Institute — Kansas City, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.